Lukas Kraehenbuehl

14PUBLICATIONS
83CO-AUTHORS
AllergyMedicinal and biomolecular chemistry not elsewhere classifiedApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Major global burdens of diseaseCellular immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Mar 26, 2026
Incidence, severity and potential pathomechanism of immune-related pruritus in melanoma patients undergoing immune checkpoint inhibitor therapy.

Andrea Roggo, Nikolina Ivanovic, Patrick Turko

|Feb 11, 2026
Dermatologic adverse events associated with amivantamab: A multicentre study.

Vasiliki Nikolaou, Ander Mayor, Vincent Sibaud

|Oct 16, 2025
Dupilumab for immune checkpoint inhibitors-induced pruritic dermatoses: A retrospective, multicentric study.

Damien Giacchero, Vincent Sibaud, Emilie Gerard

|Jun 26, 2025
Immune-Related Cutaneous Adverse Events Display Distinct Clinical and Molecular Characteristics, Depending on Immune Checkpoints Targeted.

Lukas Kraehenbuehl, Nicola Winkelbeiner, Patrick Turko

|Oct 26, 2024
Management of human epidermal growth factor receptor inhibitors-related acneiform rash: A position paper based on the first Europe/USA Delphi consensus process.

Z Apalla, A Freites-Martinez, K Grafanaki

|Apr 23, 2024
Immunologic Profiling of Immune-Related Cutaneous Adverse Events with Checkpoint Inhibitors Reveals Polarized Actionable Pathways.

Mario E Lacouture, Elena Goleva, Neil Shah

Pageof 3

Frequent Collaborators

4 joint publications

Mario E Lacouture

3 joint publications

Zoe Apalla

3 joint publications

Azael Freites-Martinez

3 joint publications

Vincent Sibaud